lecture 13: drugs for ADHD and narcolepsy

0.0(0)
Studied by 1 person
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/41

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 4:46 PM on 3/16/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

42 Terms

1
New cards

reuptake inhibitors of DA and NE

MOA of amphetamines/methylphenidate

2
New cards

○ Amphetamines displaced stored catecholamines from vesicles

○ Methylphenidates block NET enhanced reuptake and enhance NE signaling

what is the main difference between amphetamine and methylphenidate

3
New cards

atomoxetine

treatment of ADHD with a past medical history of drug abuse, use

4
New cards

weight loss, growth retardation

side effects of stimulants for ADHD in childlren

5
New cards

alpha 2 receptor agonists: clonidine, guanfacine

2nd lline treatment for ADHD in children to prevent growth retardation

6
New cards

HTN, CV effects, insomnia

most common side effects of amphetamines

7
New cards

-modafinil

-sodium oxybate

1st line agents for narcolepsy

8
New cards

Dopamine reuptake inhibitor

MOA of modafinil

9
New cards

GABA-B modulator

MOA of sodium oxybate

10
New cards

Stimulants

•Amphetamine-Dextroamphetamine mixed salts

•Methylphenidate

name the first line therapies for ADHD

11
New cards

Non-stimulants

atomosetine, guanfacine, clonidine

2nd line therapies for ADHD

12
New cards

amphetamines, methylphenidates

MOA: increases central DA and NE activity

13
New cards

amphetamines

Enter synapse using NET transporter and displace stored catecholamines from vesicles, causing reverse transport into synapse via NET

14
New cards

methylphenidates

Block NET-mediated NE reuptake and enhance NE signaling

-interfere with dopamine reuptake by blocking DAT

15
New cards

methylphenidate

MOA: Mild CNS stimulant

•***It blocks the reuptake of NE and DA into presynaptic neurons****

16
New cards

Methylphenidate (Ritalin)

considered first line stimulant in nyounger age groups

-better tolerability

17
New cards

amphetamines

MOA: Inhibit NE and DA reuptake; induce NE and DA release from vesicular storage sites into synapses → ↑↑ NE and DA

18
New cards

amphetamines

1st lline stimulant in adults

19
New cards

-Urinary alkalinizing agents (↑pH) → increase nonionized drug → ↓ excretion

-Acidification of the urine (↓pH) → increase ionized drug → ↑ excretion

describe how pH contributes to stimulant excretion

20
New cards

tics, priapism, dysphoria, psychosis

rare side effect of stimulants

21
New cards

Use w/in 14 days of MAOIs** (phenelzine, selegilin)― **risk of hypertensive crisis

contraindication of stimulants for ADHD

22
New cards

-decrease excretion--> increase toxicity

agents that alkalinize the urine __________ excretion of stimulants

23
New cards

atomoxetine

MOA : •Selective NE reuptake inhibitor (NRI)

oInhibits presynaptic reuptake of NE to increase NE in adrenergic synapse

24
New cards

atomoxetine

•**Not a controlled substance

•GI ADRs ↓(take with food or split daily dose)

•***Low risk of dependence or abuse

•No tapering required upon discontinuation

•Doesn't impact growth**

•Not recommended in pregnancy – limited data

25
New cards

guanfacine and clonidine

Role in therapy: Monotherapy or adjunctive treatment to stimulants (6-17 yo**)

26
New cards

centrally acting alpha 2A adrenergic receptor agonist

MOA of guanfacine and clonidine

27
New cards

-guanfacine: longer half life, once daily dosing

-clonidine: shorter half life, twice daily dosing

what is the difference in dosing guanfacine and clonidine

28
New cards

XR (extended release)

only _____ formulations of clonidine and guanfacine are FDA approved to treat ADHD

29
New cards

atomoxetine, guanfacine, and bupropion

2nd line treatments for ADHD for those whoa re unresponsive or are unable to tolerate stimulants

30
New cards

-excessive day time somnonlence/intrusive drowsiness

-cataplexy

-hallucinations

-sleep paralysis

what is the tetrad of narcolepsy?

31
New cards

narcolepsy

caused by loss of normal function of hypocretin (orexin) system

32
New cards

•Modafinil/Armodafinil

•Sodium oxybate

main treatments for the excessive daytime somnnolence symptoms of narcolepsy

33
New cards

modafinil and armodafinil

•Wakefulness-promoting agents**

•Non-amphetamine CNS stimulants (less potential for abuse**)

34
New cards

•Inhibition of DA reuptake (weak*) → stimulate hypocretin (orexin)-containing neurons in prefrontal cortex and hypothalamus

•Increase levels of DA in the nucleus accumbens

MOA of modafinil and armodafinil

35
New cards

modafinil

Modafinil induces cytochrome P450 enzymes (CYP3A4), which increases estrogen metabolism, reducing the effectiveness of birth control pills

decreases the efficacy of oral combined contraceptive pills and antiseizure meds

36
New cards

sodium oxybate

MOA: CNS depressant that acts on GABA-B receptors, promoting deep sleep and reducing cataplexy (GABA-B modulator**)

37
New cards

atomoxetine

antidepressants

off lalbel use of TCAs, SNRIs, SSRIs

-seleggiline

classes of drugs for cataplexy

38
New cards

insomnia and anxiety

most common side effect of modafinil

39
New cards

alcohol

______ should be avoided when taking sodium oxybate

40
New cards

modafinil

has a lower risk that amphetamines in excacerbating anxiety

41
New cards

Armodafinil is the longer-acting R-enantiomer of modafinil

how is armondafil differ from modafinil?

42
New cards

opioids

take _____ with cation while on oxybate